| 产品名称 | INNO 406 - Bafetinib |
| 产品货号 | Axon 2121 CAS [859212-16-1] MF C30H31F3N8OMW 576.62 Purity: 99% Optical purity: Optically pure Soluble in 0.1N HCl(aq) and DMSO Description Orally bioavailable dual Bcr-Abl and Lyn kinase inhibitor with anti-CML efficacy; orally bioavailable; more potent (>10 times) than Imatinib; highly recommended Abl inhibitor in treating chronic myeloid leukaemia (CML) References Certificates Categories Extra info A Yokota et al. INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity. Blood, 2007, 109(1), 306-314. H Kantarjian et al. Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance. Cancer, 2010, 116(11), 2665-72. JC Uitdehaag et al. A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets. Br. J. Pharmacol. 2012, 166, 858–876. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology BCR-ABL Lyn Oncogene Fusion Proteins EC 2.7.10.1 Dual Bcr-Abl and Lyn kinase inhibitor Chemical name (S)-N-(3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide Parent CAS No. [859212-16-1] Order Size Unit Price Stock 2 mg €85.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
INNO 406 - BafetinibAxon 2121 CAS [859212-16-1] MF C30H31F3N8O
Description
Orally bioavailable dual Bcr-Abl and Lyn kinase inhibitor with anti-CML efficacy; orally bioavailable; more potent (>10 times) than Imatinib; highly recommended Abl inhibitor in treating chronic myeloid leukaemia (CML)
Dual Bcr-Abl and Lyn kinase inhibitor
Chemical name(S)-N-(3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide Parent CAS No.[859212-16-1] |
| 产品资料 |
